WGSGeneDx Holdings Corp.

$3B

FY 2022 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$235M+10.6% YoY

Gross Profit

-$27M-11.4% margin

Operating Income

-$668M-284.5% margin

Net Income

-$549M-233.9% margin

EPS (Diluted)

$-53.63

Cash Flow

Operating Cash Flow

-$319M

Free Cash Flow

-$333M

Stock-Based Comp.

$42M

Balance Sheet

Total Assets

$545M

Total Liabilities

$292M

Stockholders' Equity

$254M

Cash & Equivalents

$137M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$235M	$212M	+10.6%
Gross Profit	-$27M	-$17M	-61.1%
Operating Income	-$668M	-$446M	-49.6%
Net Income	-$549M	-$245M	-123.7%

WGS FY 2022 Earnings — GeneDx Holdings Corp. Revenue & Financial Results | Market Cap Arena